share_log
Breakings ·  Nov 7 20:00
Amylyx Pharmaceuticals Q3 Operating Income USD -75.661 Million Vs. IBES Estimate USD -52.2 Million
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment